Synthesis and Pharmacological Characterization of Conformationally Restricted Retigabine Analogues as Novel Neuronal Kv7 Channel Activators
Open accessThe DOI matches its Crossref record; 67 of the 68 references it cites were found in a registry or an index.
Abstract
Kv7 K + channels represent attractive pharmacological targets for the treatment of different neurological disorders, including epilepsy. In this paper, 42 conformationally restricted analogues of the prototypical Kv7 activator retigabine have been synthesized and tested by electrophysiological patch-clamp experiments as Kv7 agonists. When compared to retigabine (0.93 ± 0.43 μM), the EC 50 s for Kv7.2 current enhancements by compound 23a (0.08 ± 0.04 μM) were lower, whereas no change in potency was observed for 24a (0.63 ± 0.07 μM). In addition, compared to retigabine, 23a and 24a showed also higher potency in activating heteromeric Kv7.2/Kv7.3 and homomeric Kv7.4 channels. Molecular modeling studies provided new insights into the chemical features required for optimal interaction at the binding site. Stability studies evidenced improved chemical stability of 23a and 24a in comparison with retigabine. Overall, the present results highlight that the N 5-alkylamidoindole moiety provides a suitable pharmacophoric scaffold for the design of chemically stable, highly potent and selective Kv7 agonists.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Structure-guided chemistry and in silico design have produced Kv7.2/7.3-biased agonists with order-of-magnitude potency gains over retigabine, improved pharmacokinetics, and reduced liabilities linked to earlier chemotypes [265,266,267].”
From Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery (2026) · cites this paper as [266]
In the citing paper
“Subtype control is now tractable: minimal substitutions can invert activity across isoforms, enabling selective activation of Kv7.2/7.3 over Kv7.4/7.5 and allowing circuit-tailored effects [242,266,268].”
From Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery (2026) · cites this paper as [266]
Citations
Cites
Thompson, J. D., Higgins, D. G., & Gibson, T. J. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.22.4673 · Cited by 64,617
Jorgensen, W. L., Maxwell, D. S., & Tirado-Rives, J. (1996) · Journal of the American Chemical Society · doi:10.1021/ja9621760 · Cited by 15,409
Early Identification of Refractory Epilepsy
Kwan, P., & Brodie, M. J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200002033420503 · Cited by 5,204
A hierarchical approach to all‐atom protein loop prediction
Jacobson, M. P., Pincus, D. L., Rapp, C. S., Day, T. J. F., Honig, B., Shaw, D. E., & Friesner, R. A. (2004) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.10613 · Cited by 2,504
Bochevarov, A. D., Harder, E., Hughes, T. F., Greenwood, J. R., Braden, D. A., Philipp, D. M., Rinaldo, D., Halls, M. D., Zhang, J., & Friesner, R. A. (2013) · International Journal of Quantum Chemistry · doi:10.1002/qua.24481 · Cited by 1,798
Photophysics of preassociated pyrenes in aqueous polymer solutions and in other organized media
Winnik, F. M. (1993) · Chemical Reviews · doi:10.1021/cr00018a001 · Cited by 1,786
On the Role of the Crystal Environment in Determining Protein Side-chain Conformations
Jacobson, M. P., Friesner, R. A., Xiang, Z., & Honig, B. (2002) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)00470-9 · Cited by 1,267
Dixon, S. L., Smondyrev, A. M., Knoll, E. H., Rao, S. N., Shaw, D. E., & Friesner, R. A. (2006) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-006-9087-6 · Cited by 1,198
Pathways modulating neural KCNQ/M (Kv7) potassium channels
Delmas, P., & Brown, D. A. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1785 · Cited by 686
PHASE: A Novel Approach to Pharmacophore Modeling and 3D Database Searching
Dixon, S. L., Smondyrev, A. M., & Rao, S. N. (2006) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2006.00384.x · Cited by 675
Intrinsic Membrane Hyperexcitability of Amyotrophic Lateral Sclerosis Patient-Derived Motor Neurons
Wainger, B. J., Kiskinis, E., Mellin, C., Wiskow, O., Han, S. S. W., Sandoe, J., Perez, N. P., Williams, L. A., Lee, S., Boulting, G., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.03.019 · Cited by 662
Indole and Tryptophan Metabolism: Endogenous and Dietary Routes to Ah Receptor Activation
Hubbard, T. D., Murray, I. A., & Perdew, G. H. (2015) · Drug Metabolism and Disposition · doi:10.1124/dmd.115.064246 · Cited by 640
Tatulian, L., Delmas, P., Abogadie, F. C., & Brown, D. A. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-15-05535.2001 · Cited by 406
Retigabine, A Novel Anti-Convulsant, Enhances Activation of KCNQ2/Q3 Potassium Channels
Wickenden, A. D., Yu, W., Zou, A., Jegla, T., & Wagoner, P. K. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12425-x · Cited by 320
Cryo-EM Structure of a KCNQ1/CaM Complex Reveals Insights into Congenital Long QT Syndrome
Sun, J., & MacKinnon, R. (2017) · Cell · doi:10.1016/j.cell.2017.05.019 · Cited by 305
Modulation of KCNQ2/3 Potassium Channels by the Novel Anticonvulsant Retigabine
Main, M. J., Cryan, J. E., Dupere, J. R. B., Cox, B., Clare, J. J., & Burbidge, S. A. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12060-3 · Cited by 299
Conformational Restriction: An Effective Tactic in ‘Follow-On’-Based Drug Discovery
Fang, Z., Song, Y., Zhan, P., Zhang, Q., & Liu, X. (2014) · Future Medicinal Chemistry · doi:10.4155/fmc.14.50 · Cited by 268
Molecular Determinants of KCNQ (Kv7) K+Channel Sensitivity to the Anticonvulsant Retigabine
Schenzer, A., Friedrich, T., Pusch, M., Saftig, P., Jentsch, T. J., Grötzinger, J., & Schwake, M. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.0128-05.2005 · Cited by 267
Wuttke, T. V., Seebohm, G., Bail, S., Maljevic, S., & Lerche, H. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.010793 · Cited by 262
Odd−Even Effects in Charge Transport across Self-Assembled Monolayers
Thuo, M. M., Reus, W. F., Nijhuis, C. A., Barber, J. R., Kim, C., Schulz, M. D., & Whitesides, G. M. (2011) · Journal of the American Chemical Society · doi:10.1021/ja1090436 · Cited by 215
Martire, M., Castaldo, P., D'Amico, M., Preziosi, P., Annunziato, L., & Taglialatela, M. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3143-03.2004 · Cited by 175
Self-citationCompound lipophilicity for substrate binding to human P450s in drug metabolism
Lewis, D. F. V., Jacobs, M. N., & Dickins, M. (2004) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03115-0 · Cited by 172
Driving With No Brakes: Molecular Pathophysiology of Kv7 Potassium Channels
Soldovieri, M. V., Miceli, F., & Taglialatela, M. (2011) · Physiology · doi:10.1152/physiol.00009.2011 · Cited by 164
Self-citationAnxiolytic Effects of Maxipost (BMS-204352) and Retigabine via Activation of Neuronal Kv7 Channels
Korsgaard, M. P. G., Hartz, B. P., Brown, W. D., Ahring, P. K., Strøbæk, D., & Mirza, N. R. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.083923 · Cited by 141
Lange, W., Geißendörfer, J. K., Schenzer, A., Grötzinger, J., Seebohm, G., Friedrich, T., & Schwake, M. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.052282 · Cited by 132
Kalappa, B. I., Soh, H., Duignan, K. M., Furuya, T., Edwards, S., Tzingounis, A. V., & Tzounopoulos, T. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.5176-14.2015 · Cited by 105
Meyer, A., & Fischer, K. (2015) · Environmental Sciences Europe · doi:10.1186/s12302-015-0044-7 · Cited by 102
Lai, J., Chang, L., & Yuan, G. (2016) · Organic Letters · doi:10.1021/acs.orglett.6b01412 · Cited by 95
Metabolism of Retigabine (D-23129), a Novel Anticonvulsant
Hempel, R., Schupke, H., McNeilly, P. J., Heinecke, K., Kronbach, C., Grunwald, C., Zimmermann, G., Griesinger, C., Engel, J., & Kronbach, T. (1999) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15258-0 · Cited by 90
Atomic basis for therapeutic activation of neuronal potassium channels
Kim, R. Y., Yau, M. C., Galpin, J. D., Seebohm, G., Ahern, C. A., Pless, S. A., & Kurata, H. T. (2015) · Nature Communications · doi:10.1038/ncomms9116 · Cited by 89
The KCNQ2/3 selective channel opener ICA-27243 binds to a novel voltage-sensor domain site
Padilla, K. M., Wickenden, A. D., Gerlach, A. C., & McCormack, K. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.08.071 · Cited by 88
Total synthesis of (+)-CC-1065 and ent-(-)-CC-1065
Boger, D. L., & Coleman, R. S. (1988) · Journal of the American Chemical Society · doi:10.1021/ja00212a067 · Cited by 88
Direct neurotransmitter activation of voltage-gated potassium channels
Manville, R. W., Papanikolaou, M., & Abbott, G. W. (2018) · Nature Communications · doi:10.1038/s41467-018-04266-w · Cited by 82
Photoinduced C(sp3)−N Bond Cleavage Leading to the Stereoselective Syntheses of Alkenes
Yang, Z., Xu, N., Wang, C., & Uchiyama, M. (2019) · Chemistry - A European Journal · doi:10.1002/chem.201900886 · Cited by 81
Ulmschneider, S., Müller‐Vieira, U., Klein, C. D. P., Antes, I., Lengauer, T., & Hartmann, R. W. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0492397 · Cited by 80
Madabhushi, S., Jillella, R., Sriramoju, V., & Singh, R. (2014) · Green Chemistry · doi:10.1039/c4gc00246f · Cited by 74
Gabapentin Is a Potent Activator of KCNQ3 and KCNQ5 Potassium Channels
Manville, R. W., & Abbott, G. W. (2018) · Molecular Pharmacology · doi:10.1124/mol.118.112953 · Cited by 67
Synthesis and Evaluation of Potent KCNQ2/3-Specific Channel Activators
Kumar, M., Reed, N. L., Liu, R., Aizenman, E., Wipf, P., & Tzounopoulos, T. (2016) · Molecular Pharmacology · doi:10.1124/mol.115.103200 · Cited by 65
Kv7 (KCNQ) Channel Modulators and Neuropathic Pain
Munro, G., & Dalby-Brown, W. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm060989l · Cited by 62
Groseclose, M. R., & Castellino, S. (2019) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.8b00313 · Cited by 62
Borlak, J. T., Gasparic, A., Locher, M., Schupke, H., & Hermann, R. (2006) · Metabolism · doi:10.1016/j.metabol.2006.01.006 · Cited by 58
Identification of a Potent Tryptophan-Based TRPM8 Antagonist With in Vivo Analgesic Activity
Bertamino, A., Iraci, N., Ostacolo, C., Ambrosino, P., Musella, S., Sarno, V. D., Ciaglia, T., Pepe, G., Sala, M., Soldovieri, M. V., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00545 · Cited by 51
Self-citationNeuronal potassium channel openers in the management of epilepsy: role and potential of retigabine
Taglialatela, M., Barrese, Miceli, Soldovieri, Ambrosino, Iannotti, & Cilio (2010) · Clinical Pharmacology: Advances and Applications · doi:10.2147/cpaa.s15369 · Cited by 50
Self-citationBertamino, A., Ostacolo, C., Ambrosino, P., Musella, S., Sarno, V. D., Ciaglia, T., Soldovieri, M. V., Iraci, N., Fernández-Carvajal, A. M., de la Torre‐Martínez, R., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01914 · Cited by 48
Self-citationPharmacological Targeting of Neuronal Kv7.2/3 Channels: A Focus on Chemotypes and Receptor Sites
Miceli, F., Soldovieri, M. V., Ambrosino, P., Manocchio, L., Mosca, I., & Taglialatela, M. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867324666171012122852 · Cited by 48
Self-citation3,6-Bis(3-alkylguanidino)acridines as DNA-intercalating antitumor agents
Plšíková, J., Janovec, L., Kovaĺ, J., Ungvarský, J., Mikeš, J., Jendželovský, R., Fedoročko, P., Imrich, J., Kristián, P., Kašpárková, J., et al. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.09.020 · Cited by 47
Effect of the new antiepileptic drug retigabine in a rodent model of mania
Dencker, D., Dias, R., Pedersen, M. L., & Husum, H. (2008) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2007.09.023 · Cited by 45
Boger, D. L., & Zarrinmayeh, H. (1990) · The Journal of Organic Chemistry · doi:10.1021/jo00291a059 · Cited by 43
Sequence determinants of subtype‐specific actions of KCNQ channel openers
Wang, A. W., Yang, R., & Kurata, H. T. (2017) · The Journal of Physiology · doi:10.1113/jp272762 · Cited by 43
Ancient and modern anticonvulsants act synergistically in a KCNQ potassium channel binding pocket
Manville, R. W., & Abbott, G. W. (2018) · Nature Communications · doi:10.1038/s41467-018-06339-2 · Cited by 42
Pathophysiology of KCNQ Channels: Neonatal Epilepsy and Progressive Deafness
Jentsch, T. J., Schroeder, B. C., Kubisch, C., Friedrich, T., & Stein, V. (2000) · Epilepsia · doi:10.1111/j.1528-1157.2000.tb00302.x · Cited by 37
Wang, L., Qiao, G.-H., Hu, H., Gao, Z., & Nan, F. (2018) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.8b00315 · Cited by 30
Differential Effects of ICA-27243 on Cloned KV7 Channels
Blom, S. M., Schmitt, N., & Jensen, H. S. (2010) · Pharmacology · doi:10.1159/000317525 · Cited by 29
Oxidative cleavage of benzylic C–N bonds under metal-free conditions
Gong, J., Qi, X., Wei, D., Feng, J., & Wu, X. (2014) · Organic & Biomolecular Chemistry · doi:10.1039/c4ob01633e · Cited by 28
Flupirtine and retigabine as templates for ligand-based drug design of K V 7.2/3 activators
Surur, A. S., Bock, C., Beirow, K., Wurm, K. W., Schulig, L., Kindermann, M. K., Siegmund, W., Bednarski, P. J., & Link, A. (2019) · Organic & Biomolecular Chemistry · doi:10.1039/c9ob00511k · Cited by 28
Douša, M., Srbek, J., Rádl, S., Černý, J., Klecán, O., Havlı́ček, J., Tkadlecová, M., Pekárek, T., Gibala, P., & Nováková, L. (2014) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2014.01.042 · Cited by 27
Sulfide Analogues of Flupirtine and Retigabine with Nanomolar KV7.2/KV7.3 Channel Opening Activity
Bock, C., Surur, A. S., Beirow, K., Kindermann, M. K., Schulig, L., Bodtke, A., Bednarski, P. J., & Link, A. (2019) · ChemMedChem · doi:10.1002/cmdc.201900112 · Cited by 27
How to Replace the Lost keys? Strategies Toward Safer K V 7 Channel Openers
Bock, C., & Link, A. (2019) · Future Medicinal Chemistry · doi:10.4155/fmc-2018-0350 · Cited by 24
The preclinical discovery and development of ezogabine for the treatment of epilepsy
Јаnkovic, S., & Iličković, I. M. (2013) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2013.837882 · Cited by 20
Zhou, P., Zhang, Y., Xu, H., Chen, F., Chen, X., Li, X., Pi, X., Wang, L., Zhan, L., Nan, F., et al. (2014) · Molecular Pharmacology · doi:10.1124/mol.114.095190 · Cited by 20
Liu, R., Tzounopoulos, T., & Wipf, P. (2019) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.9b00097 · Cited by 19
Discovery of a retigabine derivative that inhibits KCNQ2 potassium channels
Hu, H.-N., Zhou, P., Chen, F., Li, M., Nan, F.-J., & Gao, Z.-B. (2013) · Acta Pharmacologica Sinica · doi:10.1038/aps.2013.79 · Cited by 18
Quast, H., Roß, K., Philipp, G., Hagedorn, M., Hahn, H., & Banert, K. (2009) · European Journal of Organic Chemistry · doi:10.1002/ejoc.200900350 · Cited by 17
Musella, S., Sarno, V. D., Ciaglia, T., Sala, M., Spensiero, A., Scala, M. C., Ostacolo, C., Andreï, G., Balzarini, J. M., Snoeck, R., et al. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.09.014 · Cited by 16
Self-citationA Novel Pyrene‐Based Fluorescing Amphiphile with Unusual Bulk and Interfacial Properties
Salonen, A., Knyazev, A., von Bandel, N., Degrouard, J., Langévin, D., & Drenckhan, W. (2011) · ChemPhysChem · doi:10.1002/cphc.201000627 · Cited by 15
Manville, R. W., & Abbott, G. W. (2019) · Communications Biology · doi:10.1038/s42003-019-0648-3 · Cited by 13
Pérez, H. L., Boram, S. L., & Evans, C. A. (2015) · Analytical Methods · doi:10.1039/c4ay02599g · Cited by 10
Research works printed but not linked: 3
- 10.1124/mol.58.2.253 · doi:10.1124/mol.58.2.253 · Paper page
- Hempel R., 1999, Drug Metab. Dispos., 27, 613
- 10.1124/mol.58.3.591 · doi:10.1124/mol.58.3.591 · Paper page
Cited by
Epileptic channelopathies caused by neuronal Kv7 (KCNQ) channel dysfunction
Nappi, P., Miceli, F., Soldovieri, M. V., Ambrosino, P., Barrese, V., & Taglialatela, M. (2020) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-020-02404-2 · Cited by 123
Self-citationStructural Basis for the Modulation of Human KCNQ4 by Small-Molecule Drugs
Li, T., Wu, K., Yue, Z., Wang, Y., Zhang, F., & Shen, H. (2021) · Molecular Cell · doi:10.1016/j.molcel.2020.10.037 · Cited by 92
The Role of Kv7.2 in Neurodevelopment: Insights and Gaps in Our Understanding
Dirkx, N., Miceli, F., Taglialatela, M., & Weckhuysen, S. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.570588 · Cited by 84
Self-citationAdvances in Epilepsy: Mechanisms, Clinical Trials, and Drug Therapies
Hu, T., Zhang, J., Wang, J., Sha, L., Xia, Y., Ortyl, T. C., Tian, X., & Chen, L. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01975 · Cited by 59
Discovery of HN37 as a Potent and Chemically Stable Antiepileptic Drug Candidate
Zhang, Y.-M., Xu, H.-Y., Hu, H.-N., Tian, F.-Y., Chen, F., Liu, H.-N., Zhan, L., Pi, X.-P., Liu, J., Gao, Z.-B., et al. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c02252 · Cited by 49
Metadata
- Authors
- Ostacolo, C., Miceli, F., Di Sarno, V., Nappi, P., Iraci, N., Soldovieri, M. V., Ciaglia, T., Ambrosino, P., Vestuto, V., Lauritano, A., Musella, S., Pepe, G., Basilicata, M. G., Manfra, M., Perinelli, D. R., Novellino, E., Bertamino, A., Gomez-Monterrey, I. M., Campiglia, P., & Taglialatela, M.
- Affiliations
- University of Naples Federico II (IT)
- Department of Pharmacy, University of Salerno, Via G. Paolo II 132, 84084 Fisciano, Salerno, Italy
- University of Salerno (IT)
- University of Molise (IT)
- University of Sannio (IT)
- European Biomedical Research Institute of Salerno (IT)
- University of Basilicata (IT)
- Università di Camerino (IT)
- Corresponding author
- Campiglia, Pietro
- Taglialatela, Maurizio
- ORCID
- Ostacolo, Carmine
- Miceli, Francesco
- Iraci, Nunzio
- Soldovieri, Maria Virginia
- Ciaglia, Tania
- Ambrosino, Paolo
- Vestuto, Vincenzo
- Lauritano, Anna
- Musella, Simona
- Pepe, Giacomo
- Basilicata, Manuela Giovanna
- Manfra, Michele
- Perinelli, Diego Romano
- Novellino, Ettore
- Bertamino, Alessia
- Gomez-Monterrey, Isabel M.
- Campiglia, Pietro
- Taglialatela, Maurizio
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2019-12-09
- Volume
- 63
- Issue
- 1
- Pages
- 163-185
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W2995146830
- Cited by
- 39
- References
- 68
- Citations by year
- 2026: 6 · 2025: 6 · 2024: 7 · 2023: 3 · 2022: 7 · 2021: 4 · 2020: 6
- FWCI
- 1.49
- Type
- journal article
- Language
- en
- Open access
- green
- pubs.acs.org
- Licence
- Locations
- Journal of Medicinal Chemistry (publishedVersion)
- PubMed (publishedVersion)
- CINECA IRIS Institutional Research Information System (University of Basilicata) (submittedVersion, other-oa)
- Archivio Istituzionale della Ricerca - Università degli Studi della Campania "Luigi Vanvitelli" (submittedVersion)
- Archivio Istituzionale della Ricerca - Università degli Studi del Molise (submittedVersion)
- Unicam Scientific Publications (University of Camerino) (submittedVersion)
- Funders
- Fondazione Telethon (GGP15113)
- Ministero dell’Istruzione, dell’Università e della Ricerca (2014 RBSI1444EM, PRIN 2017ALCR7C, PRIN 2017YH3SXK)
- Università degli Studi di Napoli Federico II (6-CSPUNINA-120)
- Compagnia di San Paolo (6-CSPUNINA-120)
- Ministero della Salute (GR-2016-02363337)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
- Physical Sciences › Chemistry › Organic Chemistry › Heterocyclic Compound Synthesis and Bioactivity
- Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
- Keywords
- Kv7 potassium channels, conformationally restricted compounds, Kv7.2, Kv7.3, Kv7.4, epilepsy, chemical stability, binding sites, pharmacophore, heteromeric channels
- MeSH terms
- Animals, Carbamates, Cricetulus, Indoles, Microsomes, Liver, Models, Molecular, Molecular Conformation, Mutation, Phenylenediamines, Protein Binding, Structure-Activity Relationship, Xenopus laevis, CHO Cells, KCNQ2 Potassium Channel, KCNQ3 Potassium Channel, Small Molecule Libraries
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.